Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2025-12-24 @ 5:55 PM
NCT ID:
NCT01862068
Eligibility Criteria:
Inclusion Criteria:
For patients with GPA
* Systemic or localized GPA with ACR (American College of Rheumatology) criteria.
* BVAS \> 3.
* ANCA anti-PR3 or anti-MPO
* Consent form signed
For patients with MPA
* Systemic MPA with Chapel Hill criteria.
* BVAS \> 3.
* ANCA anti-MPO
* Consent form signed
For patients with EGPA
* Systemic EGPA with ACR (American College of Rheumatology) criteria.
* BVAS \> 3.
* ANCA anti-PR3 or anti-MPO
* Consent form signed
For atherosclerotic patients
* Ischemic stroke
* Coronary heart attack
* Peripheral vascular disease responsible for intermittent claudication
* Carotid Stenosis
Exclusion Criteria:
* Pregnancy
* \<18 yr
* Malignancy
* Infectious diseases: HIV, HBV, HCV
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01862068
Study Brief:
Protocol Section:
NCT01862068